Results
Filtros
Anvisa publishes call for scientific evidence on cannabis cultivation
Agency seeks technical input for new regulation on plant cultivation in Brazil
Anvisa and scientific community discuss medicinal cannabis cultivation today (11)
Meeting is part of the agency's actions to build a technical and participatory regulation on the medicinal use of the plant
Anvisa approves two cannabis-based products for pharmacies
Pharmaceutical company Farmausa Life Science has obtained registration for its Cannabidiol in two concentrations, 20 mg/mL and 100 mg/mL, with low THC content
Anvisa orders removal of cannabis products from CBD Brasil from the market
Anvisa has prohibited the manufacturing, sale, and promotion of CBD Brasil's cannabis products due to lack of sanitary authorization
Anvisa prohibits eight cannabis products due to lack of registration
The agency determined the suspension of the commercialization and advertising of all items from the brands Golden CBD Plus and Golden CBD+ Nanotech in the national territory.
Anvisa approves new cannabis-based product in Brazil
Pharmaceutical company Ephar has obtained registration for its Cannabidiol in two concentrations, 50 mg/mL and 100 mg/mL, which will be marketed in a low THC content drop solution
Anvisa prohibits cannabis products from two companies for irregular sale; responsible parties claim to operate within the rules
Regulatory agency bans commercialization and advertising of items from the brands due to lack of sanitary authorization; understand the decision and the companies' positions
Anvisa prohibits cannabis products from Santa Catarina company due to lack of authorization
Regulatory agency determines the seizure of all batches from the company and another distributor due to irregularities in registration and manufacturing
“Extended deadline creates the possibility of presenting a more consistent proposal,” says Anvisa director about regulation of cultivation
Thiago Campos advocates for the extension of the regulation deadline and reinforces the importance of social listening in the process
Anvisa approves new cannabis-based product in Brazil
Cannten's extract with 71.33 mg/mL expands medicinal treatment options in the country and receives authorization for commercialization
Regulation of cultivation comes up for discussion at Anvisa after request for extension
10/06/2025The subject is on the agenda of the 6th Public Meeting of the Collegiate Board of Directors (Dicol) of 2025, scheduled for Wednesday (10/08)
Anvisa approves new pharmaceutical product based on cannabis in Brazil
Endogen's extract expands the portfolio of options for medicinal treatments and already has sanitary authorization for commercialization
One year after Anvisa's approval, MAPA still does not regulate veterinary cannabis
Without defined rules, veterinarians face legal uncertainty and animals still have limited access to medical cannabis treatment
Anvisa Directors Signal in Meeting with Associations that Agency Should Meet STJ Deadline to Regulate Cannabis Cultivation
Representatives of associations who participated in the meeting with the entity confirmed the delivery of the draft ordinance by September 30; Anvisa has not yet officially stated whether it will comply with the deadline set by the Judiciary, which ends today
Anvisa and Embrapa evaluate authorization for cannabis research in Brazil
Meeting aligned strategies for the development of technical and scientific knowledge about the plant, focusing on its medicinal and industrial potential
Anvisa prohibits cannabis products; companies involved claim outdated information
Agency points out irregular sale on website, but former partner claims page has been offline for over a year
Public participation in Anvisa's regulatory agenda continues until September 15
Public consultation allows society to give opinions on the agency's priorities for the next two years; preliminary list does not include cannabis
Anvisa swears in new directors in ceremony this Wednesday (10), follow it here
Live broadcast will be held on the Agency's YouTube channel; board will have a strategic role in topics such as cannabis regulation in Brazil
Anvisa has new approved directors
Confirmed appointments include Leandro Safatle, Thiago Campos, and Daniela Cerqueira
Anvisa Regulatory Agenda 2026 - 2027 opens space for society suggestions, including on cannabis
Population and regulated sectors have the opportunity to indicate topics of interest for the next biennium